VITAPHARM
DEAD

Serial Number

98900823

Owner

GREENVIT LIMITED

Attorney

Paul Ditmyer

First Use Date

Jan 1, 2006

Filing Date

Dec 16, 2024

Add to watchlist:

No watchlists yet
View on USPTO

VITAPHARM Trademark

Serial Number: 98900823

VITAPHARM is a trademark filed by GREENVIT LIMITED on December 16, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

GREENVIT LIMITED

Flat 1910 Bridgewater House
London E140TJ , GB

Entity Type: 16

Trademark Details

Filing Date

December 16, 2024

Registration Date

Not Registered

First Use Anywhere

January 1, 2006

First Use in Commerce

January 1, 2009

Goods & Services

Haemoglobin; Iodine; Anti-inflammatories; Anti-inflammatory gels; Anti-inflammatory ointments; Anti-inflammatory preparations; Calcium fortified candy for medical purposes; Collagen for medical purposes; Dietary supplements; Dietary food supplements; Eucalyptus for pharmaceutical purposes; Folic acid dietary supplements; Gastro-intestinal treatment preparations; Headache treatment preparations; Iodine for pharmaceutical purposes; Lecithin dietary supplements; Lysine preparations; Mineral food supplements; Multivitamin preparations; Nausea treatment preparations; Probiotic preparations for medical use; Probiotic supplements; Urinary tract disinfectants; Vitamin B preparations; Vitamin C preparations; Zinc supplement lozenges; Albumin dietary supplements; Alginate dietary supplements; Allergy capsules; Analgesic and anti-inflammatory preparations; Anti-inflammatory salves; Anti-inflammatory sprays; Casein dietary supplements; Central nervous system stimulants; Cod liver oil; Concentrated saline capsules for sinus and nasal irrigation; Diet capsules; Dietary supplements consisting primarily of iron; Dietary supplements consisting primarily of zinc and iron; Dietary supplements for urinary health; Enzyme food supplements; Food supplements; Fruit-based meal replacement bars for treating vitamin B12 deficiency that causes fatigue; Herbal supplements; Herbal male enhancement capsules; Homeopathic anti-inflammatory ointment; Linseed dietary supplements; Liquid herbal supplements; Mineral dietary supplements; Mineral nutritional supplements; Natural herbal supplements; Nutritional supplement shakes; Nutritional supplements in the form of capsules, tablets and liquids.; Nutritional supplements, namely, probiotic compositions; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for reducing sexual activity; Pharmaceutical preparations for the central nervous system; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Prebiotic supplements; Propolis dietary supplements; Protein supplement shakes; Stimulants for the central nervous system; Vitamin supplements; Vitamin and mineral supplements

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Oct 1, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 1, 2025 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 4, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jun 4, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jun 4, 2025 CNRT
ASSIGNED TO EXAMINER
Jun 3, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 22, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 22, 2025 NWOS
NEW APPLICATION ENTERED
Dec 16, 2024 NWAP